Susan Ottman

Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer

Rachel M. Layman, Amy S. Ruppert, M J Lynn et al. · Cancer Chemotherapy and Pharmacology · 2013 · 47 citations · Full text

Medicine, Oncology, Pharmacology +12

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab

Aruna Mani, Julie M. Roda, Donn C. Young et al. · Breast Cancer Research and Treatment · 2008 · 44 citations · Full text

Medicine, Immunology, Oncology +16

Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer

Shannon Puhalla, Ewa Mrózek, Donn C. Young et al. · Journal of Clinical Oncology · 2008 · 28 citations

Medicine, Oncology, Pharmacology +17

Phase I trial of the PARP inhibitor veliparib (V) in combination with carboplatin (C) in metastatic breast cancer (MBC).

Robert Wesolowski, Meng Zhao, Susan M. Geyer et al. · Journal of Clinical Oncology · 2014 · 16 citations

Medicine, Nuclear Medicine, Pharmacology +17